4.8 Review

The Influence of Corticosteroids, Immunosuppressants and Biologics on Patients With Inflammatory Bowel Diseases, Psoriasis and Rheumatic Diseases in the Era of COVID-19: A Review of Current Evidence

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Dermatology

Association of COVID-19 with skin diseases and relevant biologics: a cross-sectional study using nationwide claim data in South Korea

S. I. Cho et al.

Summary: The study found no significant increase in specific skin diseases or exposure to biologics among COVID-19 positive individuals, and the presence of skin diseases and exposure to biologics did not seem to affect clinical outcomes including mortality. Therefore, underlying skin diseases did not appear to increase susceptibility to COVID-19 or mortality from COVID-19.

BRITISH JOURNAL OF DERMATOLOGY (2021)

Article Rheumatology

Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry

Anja Strangfeld et al.

Summary: Factors associated with COVID-19-related death in people with rheumatic diseases include age, sex, comorbidities, disease activity, and specific medications. Adequate disease control with disease-modifying anti-rheumatic drugs (DMARDs) without increasing glucocorticoid dosages is important, while caution may be required with certain medications such as rituximab and sulfasalazine.

ANNALS OF THE RHEUMATIC DISEASES (2021)

Letter Medicine, General & Internal

Baricitinib as potential treatment for 2019-nCoV acute respiratory disease

Peter Richardson et al.

LANCET (2020)

Article Medicine, General & Internal

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Chaolin Huang et al.

LANCET (2020)

Letter Medicine, General & Internal

Covid-19 in Immune-Mediated Inflammatory Diseases - Case Series from New York

Rebecca Haberman et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Microbiology

A Retrospective Controlled Cohort Study of the Impact of Glucocorticoid Treatment in SARS-CoV-2 Infection Mortality

Ana Fernandez-Cruz et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)

Letter Immunology

ACE2 at the centre of COVID-19 from paucisymptomatic infections to severe pneumonia

Felice Rivellese et al.

AUTOIMMUNITY REVIEWS (2020)

Article Dermatology

Antecedent immunosuppressive therapy for immune-mediated inflammatory diseases in the setting of a COVID-19 outbreak

Jesse Veenstra et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)

Article Medicine, General & Internal

Effect of Hydrocortisone on 21-Day Mortality or Respiratory Support Among Critically Ill Patients With COVID-19 A Randomized Clinical Trial

Pierre-Francois Dequin et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Editorial Material Critical Care Medicine

Dexamethasone in hospitalised patients with COVID-19: addressing uncertainties

Michael A. Matthay et al.

LANCET RESPIRATORY MEDICINE (2020)

Article Medicine, General & Internal

Patients with Inflammatory Bowel Disease Are Not at Increased Risk of COVID-19: A Large Multinational Cohort Study

Mariangela Allocca et al.

JOURNAL OF CLINICAL MEDICINE (2020)

Review Biochemistry & Molecular Biology

The protective and pathogenic roles of IL-17 in viral infections: friend or foe?

Wen-Tao Ma et al.

OPEN BIOLOGY (2019)

Review Virology

Cyclophilins and cyclophilin inhibitors in nidovirus replication

Adriaan H. de Wilde et al.

VIROLOGY (2018)

Article Dermatology

Association between psoriasis and inflammatory bowel disease: a Danish nationwide cohort study

A. Egeberg et al.

BRITISH JOURNAL OF DERMATOLOGY (2016)

Review Immunology

Thalidomide: Mechanisms of action

Taraneh Paravar et al.

INTERNATIONAL REVIEWS OF IMMUNOLOGY (2008)

Article Dermatology

Polymorphisms of the IL12B and IL23R genes are associated with psoriasis

Rajan P. Nair et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2008)

Article Genetics & Heredity

A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes

Michele Cargill et al.

AMERICAN JOURNAL OF HUMAN GENETICS (2007)

Article Pharmacology & Pharmacy

Interleukin-17 and airway remodelling

A Linden

PULMONARY PHARMACOLOGY & THERAPEUTICS (2006)

Review Respiratory System

Neutrophils, interleukin-17A and lung disease

A Linden et al.

EUROPEAN RESPIRATORY JOURNAL (2005)